You are here

  • Home
  • Archive
  • Volume 70, Issue 1
  • Autologous faecal microbiota transplantation for type 1 diabetes: a potential mindshift in therapeutic microbiome manipulation?

Article Text

Article menu
Download PDFPDF
Commentary
Autologous faecal microbiota transplantation for type 1 diabetes: a potential mindshift in therapeutic microbiome manipulation?

https://doi.org/10.1136/gutjnl-2020-323252

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Twitter @gianluca1aniro, @GiovanniCammar9

    • Contributors GI: concept and writing of the manuscript. AG and GC: critical revision of the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles

    • Gut microbiota
      Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
      Pieter de Groot Tanja Nikolic Silvia Pellegrini Valeria Sordi Sultan Imangaliyev Elena Rampanelli Nordin Hanssen Ilias Attaye Guido Bakker Gaby Duinkerken Antoinette Joosten Andrei Prodan Evgeni Levin Han Levels Bartjan Potter van Loon Arianne van Bon Catherina Brouwer Sytze van Dam Suat Simsek Daniel van Raalte Frank Stam Victor Gerdes Roel Hoogma Martin Diekman Martin Gerding Cees Rustemeijer Bernadette de Bakker Joost Hoekstra Aeilko Zwinderman Jacques Bergman Frits Holleman Lorenzo Piemonti Willem De Vos Bart Roep Max Nieuwdorp
      Gut 2020; 70 92-105 Published Online First: 26 Oct 2020. doi: 10.1136/gutjnl-2020-322630